Market focus Direct-to-consumer strategy with wholesale distributors indicates two potential sales paths: expand DTC channels for sublingual delivery products and grow wholesale partnerships, including pharmacies and healthcare distributors, to broaden reach.

Product pipeline Robust upcoming lineup across sleep aids, sexual wellness, pediatric formulations, and an antibiotic on the horizon presents opportunities to secure multi-category contracts, private label opportunities, and co-development deals.

Regulatory readiness FDA registration of all products as over-the-counter and listing in the National Drug Directory lowers time-to-market for new SKUs and supports faster selling cycles with retailers and distributors.

Therapeutic focus Thin film oral delivery platform for lifestyle and addiction-related products positions RSCI to target high-margin, convenience-focused channels, including sleep, nicotine cessation, and pediatric analgesics.

Market positioning Currently 11-50 employees and mid-sized revenue band with a global leadership claim in thin film strips suggests partnership opportunities with contract manufacturers, logistics providers, and global distributors to scale manufacturing and distribution capacity.